Berlin – 22 September 2016 – International contract research organization (CRO), KCR, operating across 19 European countries as well as the U.S. has recently moved to a new office in Sofia, Bulgaria. The new KCR location in the business city center is easy to access and perfectly corroborates the company’s growth strategy in the region.
“The Balkans represent a very important region for the execution of clinical trials. KCR remains committed to strengthen its regional presence and service delivery capabilities. Office facilities are sometimes undervalued in times of home and virtual offices, but places for face-to-face interactions are crucial for a homogenous company culture in fast developing markets,” said Mike Jagielski, President & CEO, KCR. “We focus on responding to our client expectations, to be close to our partners and deliver in-depth local market knowledge.”
KCR has been present in Bulgaria since 2011. From this time on the CRO has been appreciating the country for highly efficient patient recruitment, competent medical personnel, and a stable and predictable regulatory environment. High quality data as well as a favorable cost base are perceived as additional advantages of the Bulgarian clinical research market.
"Bulgaria, along with Hungary, is one of those markets in which we benefit from the local presence and favorable market settings for conducting clinical trials,” added Head of Regional Clinical Operations Services, KCR, Katarzyna Lepecka-Czajkowska. “The new office in Sofia widely supports our services in the region with a highly competent and committed team of professionals.”
The new KCR office is located on 79, G.M.Dimitrov Blvd. in Sofia. If you are interested in cooperating with KCR in Bulgaria or would like to learn more about our operations in the country and/or in other European locations, please visit our office or contact Joanna Lewandowska, PR & Marketing, at email@example.com. Please include your full contact details in the query.
KCR is a Contract Research Organization (CRO) providing strategic clinical development solutions for the pharmaceutical, biotechnology and medical device industries in Europe, Israel and the U.S. More than 300 professionals support clients with full-service capabilities across our three main service areas: Trial Execution (TE), Functional Service Provision (FS) and Late Phase (LP). Focusing on knowledge, quality and innovation, KCR delivers high value solutions customized to clients' needs. Headquartered in Berlin, Germany, KCR operates across 19 countries in Europe as well as the U.S. For more information, visit www.kcrcro.com.
KCR: We see human behind every number.
Associate Director, PR & Marketing
mobile: (+48) 605 053 164